Skip to main content

Table 3 Univariate log-rank and multivariate analyses for overall and disease-specific survivals in primary localized IHCC

From: Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma

Parameter

Category

Case No

Overall survival

Disease-specific survival

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

No. of event

p-value

R.R

95% C.I

p-value

No. of event

p-value

R.R

95% C.I

p-value

Gender

Male

108

50

0.0254*

1

–

0.105

9

0.0072*

1

–

0.048*

Female

74

21

 

1.532

0.914–2.566

–

32

 

2.118

1.006–4.457

–

Age (years)

 < 65

107

37

0.2626

–

–

-

28

0.2125

–

–

–

 ≥ 65

75

34

 

–

–

-

13

 

–

–

–

Hepatitis

Hepatitis B

72

32

0.2379

–

–

-

16

0.4561

–

–

–

Hepatitis C

29

8

 

–

–

–

19

 

–

–

–

Non-B, non-C

81

31

 

–

–

–

6

 

–

–

–

Intrahepatic lithiasis

Not identified

102

36

0.2831

–

–

–

19

0.1613

–

–

–

Present

80

35

 

–

–

–

22

 

–

–

–

Surgical margin

R0

163

59

 < 0.0001*

1

–

0.004*

31

 < 0.0001*

1

–

 < 0.001*

R1

19

12

 

2.756

1.389–5.467

 

10

 

4.523

2.020–10.126

 

Primary tumor (T)

T1

87

25

0.0001*

1

–

0.020*

9

 < 0.0001*

1

–

0.004*

T2

61

27

 

1.783

1.029–3.089

–

19

 

3.521

1.583–7.830

–

T3

34

19

 

2.371

1.242–4.524

–

13

 

3.735

1.519–9.184

–

Histological variants

Large duct type

105

43

0.4281

–

–

–

27

0.1984

–

–

–

Small duct type

77

28

 

–

–

–

14

 

–

–

–

Histological Grade (Differentiation)

Well

61

20

0.1663

–

–

–

12

0.3881

–

–

–

Moderately

66

28

 

–

–

–

16

 

–

–

–

Poorly

55

23

 

–

–

–

13

 

–

–

–

UBE2C Exp

Low expression

91

28

0.0013

1

–

0.046*-

13

0.0004*

1

–

0.019*-

High expression

91

43

 

1.668

1.068–2.758

–

28

 

2.289

1.143–4.583

–

  1. * Statistically significant